Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
R-2487 by Rise Therapeutics for Rheumatoid Arthritis: Likelihood of Approval
R-2487 is under clinical development by Rise Therapeutics and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...